Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial

The prognostic value of (18)F-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) at baseline or the predictive value of minimal residual disease (MRD) detection appear as potential tools to improve mantle cell lymphoma (MCL) patients’ management. The LyMa-101, a phase 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodet-Milin, Caroline, Morvant, Cyrille, Carlier, Thomas, Frecon, Gauthier, Tournilhac, Olivier, Safar, Violaine, Kraeber-Bodere, Françoise, Le Gouill, Steven, Macintyre, Elizabeth, Bailly, Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598231/
https://www.ncbi.nlm.nih.gov/pubmed/37875524
http://dx.doi.org/10.1038/s41598-023-45215-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598231/
https://www.ncbi.nlm.nih.gov/pubmed/37875524
http://dx.doi.org/10.1038/s41598-023-45215-y

Ejemplares similares